Neoplasms, Nerve Tissue: Clinical Trials

15 trials for Neoplasms, Nerve Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Unknown 15

Follow Neoplasms, Nerve Tissue: new trials by email Literature Review of Neoplasms, Nerve Tissue trials Research Report on Neoplasms, Nerve Tissue

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG
MSOT - Melanoma, Stage I, Melanoma, Stage II
Phase 4UnknownUniversity Medical Center Groningen102022-09-012022-07-20
The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome
N-Acetyl cysteine, Wrist Splint - Carpal Tunnel Syndrome, Hand Injuries and Disorders
Phase 4UnknownEmily Krauss2402022-04-012024-08-23
The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
Pembrolizumab - Newly Diagnosed Glioblastoma
Phase 4UnknownMedical University of Silesia362022-03-012023-08-31
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
Nivolumab - Melanoma
Phase 4UnknownErasmus Medical Center342022-01-052024-04-22
Tranexamic Acid Reduce Blood Loss in Meningioma Resection
Tranexamic acid, Placebo - Meningioma
Phase 4UnknownChiang Mai University442021-09-012021-01-27
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
Lymphoseek, Nanocoll - Head Cancer, Neck Cancer
Phase 4UnknownAnna Cruceta302020-03-012020-02-20
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Nivolumab, MRI, BLOOD SAMPLES - Melanoma, Non-small Cell
Phase 4UnknownAssistance Publique Hopitaux De Marseille502018-04-092023-04-21
Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET
Lanreotide - Neuroendocrine Tumors
Phase 4UnknownSamsung Medical Center282017-07-052019-05-20
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
GM-CSF, G-CSF, GM-CSF and G-CSF - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 4UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine4052016-09-272018-10-17
Nonfunctional Pancreatic NET and PET Imaging
PET/CT - Diagnosis
Phase 4UnknownTurku University Hospital202015-12-012016-01-06
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
Triamcinolone Acetonide, Transpupillary thermotherapy - Exudative Retinal Detachment, Uveal Melanoma
Phase 4UnknownCharite University, Berlin, Germany502015-01-012017-02-08
Radiolabeled Molecules for Medullary Thyroid Cancer
Lu 177 - Medullary Thyroid Cancer
Phase 4UnknownInstituto Nacional de Cancer, Brazil202013-08-012016-09-07
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Hydrocortisone, Prednisone - Pituitary Neoplasms, Craniopharyngiomas
Phase 4UnknownWest China Hospital1002013-08-012014-07-15
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Ranibizumab - Uveal Melanoma, Radiation Retinopathy
Phase 4UnknownShields, Shields and Associates4002007-04-012007-10-08
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Cisplatin, Vindesine, Dacarbazine (drugs) - Metastatic Melanoma
Phase 4UnknownDermatologic Cooperative Oncology Group2002001-09-012006-06-21

Narrower conditions

Melanoma (5)  ·  Disease (2)  ·  Neuroendocrine Tumors (2)  ·  Uveal Melanoma (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Medullary (1)  ·  Carpal Tunnel Syndrome (1)  ·  Craniopharyngioma (1)  ·  Glioblastoma (1)  ·  Hand Injuries (1)  ·  Head and Neck Neoplasms (1)  ·  Hemorrhage (1)  ·  Hepatoblastoma (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lung Neoplasms (1)

Broader conditions

Neoplasms (15)  ·  Neoplasms by Histologic Type (15)  ·  Neoplasms, Germ Cell and Embryonal (13)  ·  Neuroectodermal Tumors (13)  ·  Neoplasms by Site (10)  ·  Neuroendocrine Tumors (8)  ·  Nevi and Melanomas (7)  ·  Skin Diseases (5)  ·  Skin Neoplasms (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Eye Diseases (3)  ·  Eye Neoplasms (3)

Interventions

Nivolumab (2)  ·  Acetylcysteine (1)  ·  Blood Specimen Collection (1)  ·  Cisplatin (1)  ·  Dacarbazine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Hydrocortisone (1)  ·  Lutetium-177 (1)  ·  Pharmaceutical Preparations (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Prednisone (1)  ·  Ranibizumab (1)  ·  Sensitivity Training Groups (1)  ·  Tranexamic Acid (1)

Sponsors

Anna Cruceta (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Charite University, Berlin, Germany (1)  ·  Chiang Mai University (1)  ·  Dermatologic Cooperative Oncology Group (1)  ·  Emily Krauss (1)  ·  Erasmus Medical Center (1)  ·  Instituto Nacional de Cancer, Brazil (1)  ·  Medical University of Silesia (1)  ·  Samsung Medical Center (1)  ·  Shields, Shields and Associates (1)  ·  Turku University Hospital (1)  ·  University Medical Center Groningen (1)  ·  West China Hospital (1)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (2)  ·  Germany (2)  ·  Brazil (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Axel Hauschild, MD (1)  ·  Carol L Shields, MD (1)  ·  Fang Yongjun, Ph.D (1)  ·  Fernanda Vaisman, MD, PhD (1)  ·  Gao Fei, Ph.D (1)  ·  Hu Shaoyan, Ph.D (1)  ·  Ira Seibel, MD (1)  ·  Jens Ulrich, MD (1)  ·  Li Aimin, Ph.D (1)  ·  Liang Changda, Master (1)  ·  Liu Wei, Ph.D (1)  ·  Michael Bezuhly, MD (1)  ·  Pan Kaili, Master (1)  ·  Pathomporn Pin-on, MD (1)

Results publications

PMID 31872324, PMID 35230185

NIH funding

2017 (1), 2019 (1)